{"nctId":"NCT01402492","briefTitle":"Cocaine Use Reduction With Buprenorphine","startDateStruct":{"date":"2011-09"},"conditions":["Cocaine Dependence"],"count":302,"armGroups":[{"label":"BUP4+XR-NTX","type":"EXPERIMENTAL","interventionNames":["Drug: Buprenorphine + Naltrexone"]},{"label":"BUP16+XR-NTX","type":"EXPERIMENTAL","interventionNames":["Drug: Buprenorphine + Naltrexone"]},{"label":"PLB+XR-NTX","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Placebo + Naltrexone"]}],"interventions":[{"name":"Buprenorphine + Naltrexone","otherNames":["Suboxone","buprenorphine/naloxone","Vivitrol","extended release injectable naltrexone"]},{"name":"Placebo + Naltrexone","otherNames":["Vivitrol","extended release injectable naltrexone"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 18 to 65 years of age\n* In good general health\n* Meet Diagnostic and Statistical Manual (DSM)-IV criteria for cocaine dependence\n* Meet DSM-IV criteria for past-year opioid dependence OR past-year opioid abuse OR have past-year opioid use and a history of opioid dependence during the lifetime\n* Interested in receiving treatment for cocaine dependence\n* Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study\n* Able to satisfy and comply with study procedures and requirements\n* If female of childbearing potential, willing to practice and effective method of birth control for the duration of the study\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding females\n* Known allergy or sensitivity to study medications\n* Recent or ongoing treatment with medications that, in the judgment of the study medical clinician, could interact adversely with study drugs or interfere with study participation\n* Have a current pattern of alcohol, benzodiazepine, or other sedative-hypnotic use, as determined by the study medical clinician, which would preclude safe participation\n* Liver function test results greater than 5 times the upper limit of normal or other exclusionary clinical lab test values\n* Serious medical condition or acute psychiatric disorder that would make study participation difficult or unsafe\n* Pending action or situation that might prevent remaining in the area for the duration of the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Cocaine Use Days as Measured by Self-report, Corroborated by Thrice-weekly Urine Drug Screens","description":"Self-reported days of cocaine use corroborated with urine drug screens (UDS).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"5.25"},{"groupId":"OG001","value":"7.2","spread":"6.77"},{"groupId":"OG002","value":"7.7","spread":"6.16"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":13,"n":100},"commonTop":["Nausea","Vomiting","Constipation","Dizziness","Diarrhea"]}}}